# LENSAR, Inc. (LNSR)

> Source: Nexqual · https://nexqual.com/LNSR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, LENSAR, Inc. (LNSR), nexqual.com/LNSR" · informational, not investment advice.

**Price:** USD 6.03 (-1.31% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 6.11 · day 6.03–6.24 · 52w 4.95–12.94 · market cap $74.1M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 11.33 (range 10–13).
- Total return with dividends: 1Y -49.0% vs S&P 500 +18.1%; 5Y -19.8% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.14, revenue estimate $14.3M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 11.33 (low 10, high 13).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-28 | LUCID CAPITAL MARKETS | Initiated | Buy | $11 |
| 2026-08-20 | BTIG | Target raised | Buy | $9 → $10 |
| 2026-08-13 | BTIG | Target raised | Buy | $7 → $9 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -49.0% | -19.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -49.1% | -4.3% |
| Volatility (annualized) | 69.7% | 66.1% |
| Max drawdown | -60.6% (Jan 2026→Jul 2026) | -72.6% (Mar 2022→Oct 2023) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/LNSR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt